VIGNALI Laboratory

Identification of the Docking Site for CD3 on the T Cell Receptor β Chain by Solution NMR.

He Y, Rangarajan S, Kerzic M, Luo M, Chen Y, Wang Q, Yin Y, Workman CJ, Vignali KM, Vignali DA, Mariuzza RA, Orban J.

Inhibitory receptors as targets for cancer immunotherapy.

Turnis ME, Andrews LP, Vignali DA.

Interleukin-35: Expanding Its Job Profile.

Sawant DV, Hamilton K, Vignali DA.

Inducible T-cell receptor expression in precursor T cells for leukemia control.

Hoseini SS, Hapke M, Herbst J, Wedekind D, Baumann R, Heinz N, Schiedlmeier B, Vignali DA, van den Brink MR, Schambach A, Blazar BR, Sauer MG.

Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members.

Dixon KO, van der Kooij SW, Vignali DA, van Kooten C.

TIM-1 signaling is required for maintenance and induction of regulatory B cells.

Yeung MY, Ding Q, Brooks CR, Xiao S, Workman CJ, Vignali DA, Ueno T, Padera RF, Kuchroo VK, Najafian N, Rothstein DM.

IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.

Liu Y, Wu Y, Wang Y, Cai Y, Hu B, Bao G, Fang H, Zhao L, Ma S, Cheng Q, Song Y, Liu Y, Zhu Z, Chang H, Yu X, Sun A, Zhang Y, Vignali DA, Wu D, Liu H.